---
category: news
title: "Study Shows TIL-Based Biomarker Could Predict Checkpoint Inhibitor Response in NSCLC"
excerpt: "An AI-based test developed by South Korean biotech Lunit may improve identification of best responders to immunotherapy when used alongside PD-L1 testing"
publishedDateTime: 2022-03-25T16:01:00Z
originalUrl: "https://www.precisiononcologynews.com/biomarker-discovery-validation/study-shows-til-based-biomarker-could-predict-checkpoint-inhibitor"
webUrl: "https://www.precisiononcologynews.com/biomarker-discovery-validation/study-shows-til-based-biomarker-could-predict-checkpoint-inhibitor"
type: article
quality: 0
heat: 0
published: false

provider:
  name: precisiononcologynews
  domain: precisiononcologynews.com

topics:
  - AI in Healthcare
  - AI

secured: "gNDiA3y5C4PmRWsJeYUJzGgUCPbpGBLIu8vjY/7MT5BPXi6Z44/j5YQGsybEYzPrCJFqoi2deZKghuYxUl7JUwvoi6+hcLpF987x2pJhqGOBTiAbTW4Ejn4p1a2d45XJ1k/0VHbrMJsn0/5t9+SnjaS/JLQR1mvohfEFltRokR1sO6Gn3eYLVypd1HEjQRXASXVrs4bMqUmWKMyaXGXx7CpYZDSGfPT8x1j4EpOdvfe9cIA4VDP19172VeksRS49AY/00Uo3DFxT+mwZgYE9wukz5R7JqG8I27cCYVrXHlYxMZh5qpGjMJUMqzYzf33Zl/KtXJBjfeAJ9LSku3OrGE0z8PMw51jngdMfg/0vY8k=;5DeUiEJGk5m1DGfImiJdOA=="
---

